Showing results (371-380 of 470) with videos related to

Sort By:
Pageof 47
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 10, 2026
A Practical Strategy for Primary Aldosteronism Subtyping: Leveraging the Unilateral Adrenal Vein Sampling Index When Bilateral Cannulation FailsQing-Rong Deng, Xiang Cao, Jun Deng, et al.
Antimicrobial Agents and Chemotherapy|July 7, 2016
Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy VolunteersJeremy J Lim, Rong Deng, Michael A Derby, et al.
European Journal of Radiology|May 3, 2026
Ultra-high resolution Photon-Counting CTA for follow-up assessment of intracranial aneurysms after flow diverter: Initial experienceRuixi Li, Naying He, Ying Cui, et al.
Chinese Journal of Cancer|July 2, 2010
A novel sesquiterpene Hirsutanol A induces autophagical cell death in human hepatocellular carcinoma cells by increasing reactive oxygen speciesFen Yang, You-Heng Gao, Ke-Wei Wu, et al.
Mabs|June 20, 2013
A strategy for risk mitigation of antibodies with fast clearanceIsidro Hötzel, Frank-Peter Theil, Lisa J Bernstein, et al.
Oncotarget|March 13, 2015
Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitorsXiao-jun Qian, Yun-tian Li, Yan Yu, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 24, 2019
ZTW-41, a Potent Indolizinoquinoline-5,12-Dione Derivative Against Drug-Resistant <i>Staphylococci</i> and <i>Enterococci</i> BacteriaChong-Fa Lai, Wei-Bin Xiao, Hua-Cheng Yan, et al.
Advanced Drug Delivery Reviews|February 4, 2024
Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findingsMichael Z Liao, Dan Lu, Tong Lu, et al.
Clinical and Translational Science|May 29, 2024
Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphomaBrendan Bender, Chi-Chung Li, Mathilde Marchand, et al.
Plos One|October 2, 2012
The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatmentDan-Dan Li, Ting Sun, Xiao-Qi Wu, et al.
Pageof 47